Meet our team in Berlin to learn how Prosigna Breast Cancer Assay was developed from the four PAM50 intrinsic subtypes and provides better prognostic accuracy.

If you would like to book a meeting with the Veracyte team during ESMO Breast, please use the BOOK A MEETING link below.